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As a model for HTLV, reverse genetics can be used in
the bovine leukemia virus (BLV) system to identify
important mechanisms of viral persistence and patho-
genesis. The question addressed here pertains to the
role of glycans bound to the BLV envelope glycoprotein
(SU gp51). Addition of carbohydrates to the BLV SU
potentially creates a structure called « glycan shield »
that confers resistance to the virus against the host
immune response. On the other hand, glycosylation can
also modulate attachment of the virus to the cell
membrane.
To unravel the role of SU glycosylation, three comple-
mentary strategies were developed: pharmacological
inhibition of different glycosylation pathways, interfer-
ence with glycan attachment and site-directed mutagen-
esis of N-glycosylation sites in an infectious BLV
provirus. Collectively, our results demonstrate that gly-
cosylation is important for the Gp51 maturation process,
for virus infection in vitro and for infectivity in vivo.
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